Eargo announces receipt of nasdaq non-compliance letter

San jose, calif., may 13, 2022 (globe newswire) -- eargo, inc. (nasdaq: ear) (the “company” or “eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the company received a letter (the “letter”) from the nasdaq stock market llc (“nasdaq”) notifying the company that because it remains delinquent in filing its quarterly report on form 10-q for the quarterly period ended september 30, 2021 and its annual report on form 10-k for the fiscal year ended december 31, 2021, and because it is delinquent in filing its quarterly report on form 10-q for the quarterly period ended march 31, 2022, it has not regained compliance with nasdaq listing rule 5250(c)(1), which requires timely filing of periodic reports with the securities and exchange commission.
EAR Ratings Summary
EAR Quant Ranking